PEGZEREPOETIN ALFA: 399 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
399
Total FAERS Reports
195 (48.9%)
Deaths Reported
143
Hospitalizations
399
As Primary/Secondary Suspect
16
Life-Threatening
6
Disabilities
First Report: 201103 · Latest Report: 20150612
What Are the Most Common PEGZEREPOETIN ALFA Side Effects?
#1 Most Reported
Death
100 reports (25.1%)
#2 Most Reported
Haemoglobin decreased
20 reports (5.0%)
#3 Most Reported
Hypertension
19 reports (4.8%)
All PEGZEREPOETIN ALFA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 100 | 25.1% | 100 | 9 |
| Haemoglobin decreased | 20 | 5.0% | 3 | 5 |
| Hypertension | 19 | 4.8% | 9 | 11 |
| Aplasia pure red cell | 17 | 4.3% | 1 | 5 |
| Anaemia | 16 | 4.0% | 1 | 6 |
| Cardiac failure | 15 | 3.8% | 7 | 7 |
| Cerebrovascular accident | 12 | 3.0% | 6 | 6 |
| Pneumonia | 12 | 3.0% | 7 | 8 |
| Fall | 10 | 2.5% | 3 | 7 |
| Cardiac arrest | 9 | 2.3% | 8 | 2 |
| Cerebral infarction | 9 | 2.3% | 3 | 8 |
| Myocardial infarction | 9 | 2.3% | 7 | 2 |
| Renal impairment | 9 | 2.3% | 3 | 5 |
| Sepsis | 9 | 2.3% | 8 | 3 |
| Disease progression | 8 | 2.0% | 8 | 0 |
| Drug ineffective | 8 | 2.0% | 0 | 1 |
| Cardiac failure congestive | 7 | 1.8% | 3 | 5 |
| Cerebral haemorrhage | 7 | 1.8% | 5 | 3 |
| Renal failure | 7 | 1.8% | 4 | 1 |
| Chronic kidney disease | 6 | 1.5% | 3 | 5 |
Who Reports PEGZEREPOETIN ALFA Side Effects? Age & Gender Data
Gender: 45.9% female, 54.1% male. Average age: 69.7 years. Most reports from: JP. View detailed demographics →
Is PEGZEREPOETIN ALFA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 2 | 1 | 1 |
| 2012 | 28 | 12 | 14 |
| 2013 | 51 | 20 | 28 |
| 2014 | 93 | 37 | 43 |
| 2015 | 73 | 31 | 29 |
What Is PEGZEREPOETIN ALFA Used For?
| Indication | Reports |
|---|---|
| Nephrogenic anaemia | 325 |
| Product used for unknown indication | 42 |
| Anaemia | 21 |
| Chronic kidney disease | 6 |
PEGZEREPOETIN ALFA vs Alternatives: Which Is Safer?
PEGZEREPOETIN ALFA vs PEMBROLIZUMAB
PEGZEREPOETIN ALFA vs PEMETREXED
PEGZEREPOETIN ALFA vs PEMIGATINIB
PEGZEREPOETIN ALFA vs PENICILLAMINE
PEGZEREPOETIN ALFA vs PENICILLIN
PEGZEREPOETIN ALFA vs PENICILLIN G
PEGZEREPOETIN ALFA vs PENICILLIN G BENZATHINE
PEGZEREPOETIN ALFA vs PENICILLIN G PROCAINE
PEGZEREPOETIN ALFA vs PENICILLIN V
PEGZEREPOETIN ALFA vs PENICILLIN V BENZATHINE
Official FDA Label for PEGZEREPOETIN ALFA
Official prescribing information from the FDA-approved drug label.